Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis

HIV Medicine

Volumn 18, Issue 4, 2017, Pages 256-266

  Teeraananchai, S ^a,b   Kerr, S J ^a,b,c   Amin, J ^a   Ruxrungtham, K ^b,d   Law, M G ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

combination antiretroviral therapy; HIV; life expectancy; meta analysis

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIRETROVIRAL THERAPY; ARTICLE; COHORT ANALYSIS; COMBINATION DRUG THERAPY; HIGH INCOME COUNTRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; LOW INCOME COUNTRY; META ANALYSIS; MIDDLE INCOME COUNTRY; PRIORITY JOURNAL; ADOLESCENT; ADULT; AGED; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; MALE; MIDDLE AGED; PROCEDURES; SURVIVAL ANALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84980642001     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12421     Document Type: Article

References (35)

1. WHO. WHO Methods for Life Expectancy and Healthy Life Expectancy. Geneva, World Health Organization, 2014: 1–24.
2. UNAIDS. Report on the global AIDS epidemic, Chapter 4: The impact of AIDS on People and Societies' 2006.
3. UNDP. Human development report: The Rise of the South: Human Progress in a Diverse World. United Nations Development Programme. Vol 2016, 2013.
4. May M, Sterne JA, Sabin C et al. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS 2007; 21: 1185–1197.
5. Nakagawa F, May M, Phillips A. Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis 2013; 26: 17–25.
6. Mahy M, Stover J, Stanecki K, Stoneburner R, Tassie JM. Estimating the impact of antiretroviral therapy: regional and global estimates of life-years gained among adults. Sex Transm Infect 2010; 86(Suppl 2): ii67–ii71.
7. WHO. Progress on Global Access to HIV Antiretroviral Therapy. An Update on “3 by 5”, March 2006. Geneva, World Health Organization, 2006.
8. May MT, Ingle SM. Life expectancy of HIV-positive adults: a review. Sex Health 2011; 8: 526–533.
9. Sabin CA. Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy? BMC Med 2013; 11: 251.
10. World Bank. Country and Lending Groups 2015. Available at http://data.worldbank.org/about/country-and-lending-groups (accessed 15 June 2015).
11. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8: 336–341.
12. Chiang CL. On constructing current life tables. JASA 1972; 67: 538–541.
13. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–634.
14. Guaraldi G, Cossarizza A, Franceschi C et al. Life expectancy in the immune recovery era: the evolving scenario of the HIV epidemic in northern Italy. J Acquir Immune Defic Syndr 2014; 65: 175–181.
15. May M, Gompels M, Delpech V et al. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ 2011; 343: d6016.
16. May MT, Gompels M, Delpech V et al. Impact on life expectancy of HIV-1 positive individuals of CD4 + cell count and viral load response to antiretroviral therapy. AIDS 2014; 28: 1193–1202.
17. Collaboration Antiretroviral Therapy Cohort. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008; 372: 293–299.
18. Samji H, Cescon A, Hogg RS et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013; 8: e81355.
19. Mills EJ, Bakanda C, Birungi J et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med 2011; 155: 209–216.
20. Johnson LF, Mossong J, Dorrington RE et al. Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med 2013; 10: e1001418.
21. Nsanzimana S, Remera E, Kanters S et al. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study. Lancet Glob Health 2015; 3: e169–e177.
22. Lima VD, Eyawo O, Ma H et al. The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada. J Int AIDS Soc 2015; 18: 20261.
23. Lima VD, Hogg RS, Harrigan PR et al. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS 2007; 21: 685–692.
24. Lloyd-Smith E, Brodkin E, Wood E et al. Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia. AIDS 2006; 20: 445–450.
25. Patterson S, Cescon A, Samji H et al. Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada. BMC Infect Dis 2015; 15: 274.
26. Helleberg M, May MT, Ingle SM et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS 2015; 29: 221–229.
27. WHO Life tables by World Bank Income Group. Available at http://apps.who.int/gho/data/view.main.LIFEWBLMI?lang=en (accessed 24 July 2015).
28. WHO Life tables by country. Available at http://www.who.int/gho/countries/en/ (accessed 11 April 2016).
29. Bor J, Rosen S, Chimbindi N et al. Mass HIV treatment and sex disparities in life expectancy: demographic surveillance in rural South Africa. PLoS Med 2015; 12: e1001905; discussion e1001905.
30. Tsai AC, Siedner MJ. The missing men: HIV treatment scale-up and life expectancy in Sub-Saharan Africa. PLoS Med 2015; 12: e1001906.
31. WHO/UNAIDS. Gobal Update on HIV Treatment 2013: Results, Impact and Opportunities. Geneva, World Health Organization, 2013.
32. Losina E, Schackman BR, Sadownik SN et al. Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis 2009; 49: 1570–1578.
33. van Sighem AI, Gras LA, Reiss P, Brinkman K, de Wolf F, study Anoc. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS 2010; 24: 1527–1535.
34. Lohse N, Hansen AB, Pedersen G et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007; 146: 87–95.
35. Egger M, Johnson LF. Estimating trends in life expectancy in HIV-positive individuals. Lancet Glob Health 2015; 3: e122–e123.